Comparison of Robot-assisted Laparoscopic Myomectomy With Traditional Laparoscopic Myomectomy

This study has been completed.
Information provided by (Responsible Party):
Sheng-Mou Hsiao, Far Eastern Memorial Hospital Identifier:
First received: February 26, 2012
Last updated: March 1, 2012
Last verified: February 2012

This study is to reveal any potential advantage of Robot-assisted Laparoscopic Myomectomy (RLAM) over Traditional Laparoscopic Myomectomy (TLM) by comparing the perioperative variables and short-term outcome of RALM and TLM patients.

Uterine Myoma

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective

Further study details as provided by Far Eastern Memorial Hospital:

Primary Outcome Measures:
  • amount of postoperation abdominal drainage [ Time Frame: 5 days ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • operation time [ Time Frame: 1 day ] [ Designated as safety issue: No ]
  • blood loss [ Time Frame: 1 day ] [ Designated as safety issue: No ]

Enrollment: 42
Study Start Date: February 2012
Study Completion Date: February 2012
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
uterine myoma

Detailed Description:

All patients with symptomatic uterine myomas who underwent traditional laparoscopic myomectomy or robotic laparoscopic myomectomy were enrolled.


Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with uterine myoma, and underwent primary treatment (RALM and TLM) in Far Eastern Memorial Hospital


Inclusion Criteria:

  • cases with uterine myoma
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01542658

Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
Banqiao, New Taipei, Taiwan, 22050
Sponsors and Collaborators
Far Eastern Memorial Hospital
  More Information

No publications provided

Responsible Party: Sheng-Mou Hsiao, Chief, Department of Obstetrics & Gynecology, Far Eastern Memorial Hospital Identifier: NCT01542658     History of Changes
Other Study ID Numbers: 100167-E
Study First Received: February 26, 2012
Last Updated: March 1, 2012
Health Authority: Taiwan: Institutional Review Board

Additional relevant MeSH terms:
Connective Tissue Diseases
Neoplasms by Histologic Type
Neoplasms, Connective Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms, Muscle Tissue processed this record on October 09, 2015